Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-10,000
Closed -$4.65M 5432
2021
Q3
$4.65M Hold
10,000
﹤0.01% 2164
2021
Q2
$4.75M Buy
+10,000
New +$4.8M ﹤0.01% 2094
2020
Q1
Sell
-20,000
Closed -$8.79M 3953
2019
Q4
$8.79M Hold
20,000
0.01% 1298
2019
Q3
$8.35M Buy
+20,000
New +$8.16M 0.01% 1286
2018
Q4
Sell
-10,000
Closed -$3.2M 3774
2018
Q3
$3.2M Sell
10,000
-11,100
-53% -$3.54M ﹤0.01% 1874
2018
Q2
$6.79M Buy
21,100
+4,800
+29% +$1.5M 0.01% 1323
2018
Q1
$4.45M Buy
16,300
+1,300
+9% +$344K 0.01% 1489
2017
Q4
$3.65M Buy
+15,000
New +$3.41M 0.01% 1712
2014
Q2
Sell
-7,000
Closed -$626K 4220
2014
Q1
$626K Buy
+7,000
New +$570K ﹤0.01% 3411

Other funds holding CHE

David Shaw's CHE Position: Q2 2026 in Review

David Shaw reduced its Chemed (CHE) stake by 86% in Q2 2026, selling an estimated $15.5M and leaving 6,160 shares worth $2.87M. The position accounts for ﹤0.01% of the portfolio, ranked #2894.

David Shaw first reported a position in CHE in Q3 2014 and has held it in 37 quarters since. The position peaked at $36.9M in Q2 2018. 529 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • David Shaw held 6,160 shares of Chemed worth $2.87M as of Q2 2026.
  • David Shaw sold 36,749 Chemed shares in Q2 2026, an estimated $15.5M.
  • Chemed made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2894 holding.
  • David Shaw first reported a position in Chemed in Q3 2014 and has held it in 37 quarters since.
  • David Shaw's Chemed position peaked at $36.9M in Q2 2018.
  • 529 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.